返回
WuXi Biologics (Cayman) Inc.（02269.HK）價格
02269.HK 股價走勢圖
WUXI BIO (02269.HK)
WuXi Biologics (Cayman) Inc.
HK$37.72
-4.65%
$-1.84
盤中： Jan 19, 15:01:43 HKT
暫無資料Earnings FAQ
02269.HK 最近的每股盈餘與預期相比如何？
WuXi Biologics (Cayman) Inc. 02269.HK 上一季度的收入表現如何？
WuXi Biologics (Cayman) Inc. 的收入預期是多少？
WuXi Biologics (Cayman) Inc. 的盈利品質評分是多少？
WuXi Biologics (Cayman) Inc. 何時發布財報？
WuXi Biologics (Cayman) Inc. 的預期收益是多少？
WuXi Biologics (Cayman) Inc. 是否超出收益預期？
關鍵數據
前收市價
$39.78
開盤價
$39.56
當日範圍
$37.3 - $39.7
52週區間
$16.18 - $42.6
交易量
28.2M
平均成交量
30.8M
每股盈餘 (TTM)
1.09
股息收益率
--
市值
$155.7B
什麼是 WUXI BIO？
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.